These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 17547720

  • 1. Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
    Endre ZH.
    Intern Med J; 2007 Jul; 37(7):429-31. PubMed ID: 17547720
    [No Abstract] [Full Text] [Related]

  • 2. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J.
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Cowper SE, Kuo PH, Bucala R.
    Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160
    [No Abstract] [Full Text] [Related]

  • 4. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
    Goveia M, Chan BP, Patel PR.
    J Am Acad Dermatol; 2007 Oct; 57(4):725-7. PubMed ID: 17689832
    [No Abstract] [Full Text] [Related]

  • 5. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
    Perazella MA, Rodby RA.
    Am J Med; 2007 Jul; 120(7):561-2. PubMed ID: 17602923
    [No Abstract] [Full Text] [Related]

  • 6. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Jul; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.
    Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE.
    Radiology; 2007 Mar; 242(3):647-9. PubMed ID: 17213364
    [No Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis--the beginning of the end?
    Heymann WR.
    J Am Acad Dermatol; 2007 Jul; 57(1):171-2. PubMed ID: 17572281
    [No Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 13. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Jan; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 14. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 15. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Jun; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
    Boehm I.
    Arthritis Rheum; 2008 Mar; 58(3):910; author reply 910-1. PubMed ID: 18311835
    [No Abstract] [Full Text] [Related]

  • 17. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 18. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC, Yosipovitch G, Sheehan DJ, Sangüeza OP, Greenberg CS, Sane DC.
    Am J Dermatopathol; 2007 Oct 01; 29(5):433-6. PubMed ID: 17890909
    [Abstract] [Full Text] [Related]

  • 19. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
    van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2898-903. PubMed ID: 18257437
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar 29; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.